Is There a Role for Minimal Residual Disease Monitoring in Follicular Lymphoma in the Chemo-Immunotherapy Era?

After 25 years, evaluation of minimal residual disease (MRD) in follicular lymphoma (FL) has become a standardized technique frequently integrated into clinical trials for its consistent and independent prognostic significance. Achievement of a sustained MRD negativity is a marker of treatment sensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gritti, Giuseppe, Pavoni, Chiara, Rambaldi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2017
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224815/
https://www.ncbi.nlm.nih.gov/pubmed/28101314
http://dx.doi.org/10.4084/MJHID.2017.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5224815/
https://www.ncbi.nlm.nih.gov/pubmed/28101314
http://dx.doi.org/10.4084/MJHID.2017.010

Ejemplares similares